Search research articles
Contact Us
Filters
Showing results (101-110 of 107) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 107 results.
Heliyon
|
November 18, 2024
IMM2520, a novel anti-CD47/PD-L1 bispecific antibody for cancer immune therapy
Chunmei Yang, Song Li, Dianze Chen, et al.
Frontiers in Immunology
|
July 10, 2024
Combining CD38 antibody with CD47 blockade is a promising strategy for treating hematologic malignancies expressing CD38
Song Li, Dianze Chen, Yanan Yang, et al.
Annals of Surgical Oncology
|
October 13, 2023
Treatment Patterns and Outcomes in Pancreatic Cancer: A Comparative Analysis of Ontario and the USA
Lily V Saadat, Elizabeth Schofield, Xing Bai, et al.
JAMA Network Open
|
March 22, 2022
Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial Participation
Angela K Green, Sara M Tabatabai, Xing Bai, et al.
Frontiers in Oncology
|
October 3, 2022
Radiation therapy for <i>de novo</i> anorectal cancer in patients with a history of prostate radiation therapy
Lara Hilal, Abraham J Wu, Marsha Reyngold, et al.
Journal of Neurointerventional Surgery
|
December 3, 2021
Comparing the efficacy and safety of the Skyflow device with those of the Solitaire FR stent in patients with acute ischemic stroke: a prospective, multicenter, randomized, non-inferiority clinical trial
Tengfei Zhou, Tianxiao Li, Liangfu Zhu, et al.
International Journal of Surgery (London, England)
|
December 11, 2025
125I stent plus combination therapy for HCC and portal vein tumor thrombosis: a nationwide target trial emulation
Jun-Hao Mei, Kai-Zhi Jia, Kai Zhang, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 107) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 107 results.
Heliyon
|
November 18, 2024
IMM2520, a novel anti-CD47/PD-L1 bispecific antibody for cancer immune therapy
Chunmei Yang, Song Li, Dianze Chen, et al.
Frontiers in Immunology
|
July 10, 2024
Combining CD38 antibody with CD47 blockade is a promising strategy for treating hematologic malignancies expressing CD38
Song Li, Dianze Chen, Yanan Yang, et al.
Annals of Surgical Oncology
|
October 13, 2023
Treatment Patterns and Outcomes in Pancreatic Cancer: A Comparative Analysis of Ontario and the USA
Lily V Saadat, Elizabeth Schofield, Xing Bai, et al.
JAMA Network Open
|
March 22, 2022
Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial Participation
Angela K Green, Sara M Tabatabai, Xing Bai, et al.
Frontiers in Oncology
|
October 3, 2022
Radiation therapy for <i>de novo</i> anorectal cancer in patients with a history of prostate radiation therapy
Lara Hilal, Abraham J Wu, Marsha Reyngold, et al.
Journal of Neurointerventional Surgery
|
December 3, 2021
Comparing the efficacy and safety of the Skyflow device with those of the Solitaire FR stent in patients with acute ischemic stroke: a prospective, multicenter, randomized, non-inferiority clinical trial
Tengfei Zhou, Tianxiao Li, Liangfu Zhu, et al.
International Journal of Surgery (London, England)
|
December 11, 2025
125I stent plus combination therapy for HCC and portal vein tumor thrombosis: a nationwide target trial emulation
Jun-Hao Mei, Kai-Zhi Jia, Kai Zhang, et al.
Page
of 11